The clinician decides whether treatment is appropriate and whether medication changes, spacing or additional monitoring are required
GLP-1 receptor agonists should be initiated at the lowest recommended dose and increased gradually according to the product-specific prescribing schedule
Anecdotal reports from researchers and clinicians using it for investigational purposes only further bolster this hypothesis, with many observing significant improvements in pain and function
Conagra, the first US food manufacturer to introduce GLP-1 Friendly verbiage on its packaging, is marketing six additional meals this year that feature a GLP-1 Friendly badge, according to company spokesperson Dan Hare
Hum Mol Genet 5(10):16631666 Vavreckova C, Ulrichova J, Hajduch M, Grambal F, Weigl E, Simanek V (1994) Effect of quaternary benzo[c]phenanthridine alkaloids sanguinarine, chelerythrine and fagaronine on some mammalian cells